標(biāo)題：Research Grade Aflibercept 對(duì)照抗體,AntibodySystem Laboratories

鏈接：https://www.antibodysystem.com/product/658.html

名稱：Research Grade Aflibercept 對(duì)照抗體,AntibodySystem Laboratories

CAS: 862111-32-8

貨號(hào)：DHD12629

適用物種：Human

寄主物種：Homo sapiens

形式：Liquid

純度：>95%

克隆性：Monoclonal

同種型：IgG1-Fc

應(yīng)用：Research Grade Biosimilar

UniProt：P15692

靶點(diǎn)：Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A

用途范圍：僅用于科研

儲(chǔ)存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

產(chǎn)品購(gòu)買聯(lián)系方式：027-65279366 /18162686757

郵箱：biolab-reagents@atagenix.com

QQ：2663991332

 

參考文獻(xiàn)：

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. PMID: 23084240

Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial. PMID: 35881122

Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. PMID: 28837425

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial. PMID: 34351414

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. PMID: 26935357

Intravitreal Ziv-Aflibercept: A Comprehensive Review. PMID: 31314638

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. PMID: 28106709

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial. PMID: 37535382

INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial. PMID: 35234673

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. PMID: 22949147

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. PMID: 31037289

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. PMID: 29392288

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications. PMID: 27166390

Aflibercept. PMID: 23444216

Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion. PMID: 28365905

Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration. PMID: 30813810

Aflibercept: A Review in Metastatic Colorectal Cancer. PMID: 26220913

Up-to-date role of aflibercept in the treatment of colorectal cancer. PMID: 34085884

Intravitreal Ziv-Aflibercept: Clinical Effects and Economic Impact. PMID: 28971631

Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option. PMID: 28548650

Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper. PMID: 29077188

Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy. PMID: 37504966

Aflibercept: an update on recent milestones achieved. PMID: 25588083

Aflibercept for neovascular age-related macular degeneration. PMID: 26857947

Aflibercept (VEGF-TRAP): the next anti-VEGF drug. PMID: 21999177

Aflibercept a new target therapy in cancer treatment: a review. PMID: 26224565

Aflibercept for age-related macular degeneration: a game-changer or quiet addition? PMID: 22813448

Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer. PMID: 34986714

Aflibercept for intravitreal injection: in neovascular age-related macular degeneration. PMID: 23038609

Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats. PMID: 37909622

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. PMID: 38461843

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. PMID: 30986442

Evaluation of aflibercept in the treatment of metastatic colorectal cancer. PMID: 25152076

A preclinical and clinical review of aflibercept for the management of cancer. PMID: 22264850

Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration. PMID: 23473589

Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option. PMID: 27564719

Aflibercept for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. PMID: 34908485

Aflibercept: newly approved for the treatment of macular edema following central retinal vein occlusion. PMID: 23673531

Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer. PMID: 24128964

Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. PMID: 26076760

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept. PMID: 37374329